skip to main content
Idioma:
Mostrar Somente
Refinado por: assunto: Aged remover assunto: Antineoplastic Agents remover assunto: Biological And Medical Sciences remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapy
A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapy

Segawa, Y. ; Aogi, K. ; Inoue, K. ; Sano, M. ; Sekine, I. ; Tokuda, Y. ; Isobe, H. ; Ogura, T. ; Tsuboi, M. ; Atagi, S.

Annals of oncology, 2009-11, Vol.20 (11), p.1874-1880 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
2
Expression of peroxisome proliferator‐activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists
Expression of peroxisome proliferator‐activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists
Material Type:
Artigo 		Adicionar ao Meu Espaço

Expression of peroxisome proliferator‐activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists

Yoshimura, Rikio ; Matsuyama, Masahide ; Segawa, Yoshihiro ; Hase, Taro ; Mitsuhashi, Makoto ; Tsuchida, Kennji ; Wada, Seiji ; Kawahito, Yutaka ; Sano, Hajime ; Nakatani, Tatsuya

International journal of cancer, 2003-05, Vol.104 (5), p.597-602 [Periódico revisado por pares]

New York: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
3
Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer
Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer

KAWAHARA, M ; FURUSE, K ; SEGAWA, Y ; YOSHIMORI, K ; MATSUI, K ; KUDOH, S ; HASEGAWA, K ; NIITANI, H

British journal of cancer, 2001-09, Vol.85 (7), p.939-943 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
γ-Aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism
γ-Aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism
Material Type:
Artigo 		Adicionar ao Meu Espaço

γ-Aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism

AZUMA, Haruhito ; INAMOTO, Teruo ; TAKAHARA, Kiyoshi ; KATSUOKA, Yoji ; WATANABE, Masahito ; SAKAMOTO, Takeshi ; KIYAMA, Satoshi ; UBAI, Takanobu ; SHINOHARA, Yuko ; MAEMURA, Kentaro ; TSUJI, Motomu ; SEGAWA, Naoki ; MASUDA, Hiroshi

Cancer research (Chicago, Ill.), 2003-12, Vol.63 (23), p.8090-8096 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
5
Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patients
Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patients

TAKIGAWA, Nagio ; SEGAWA, Yoshihiko ; GEMBA, Kenichi ; TABATA, Masahiro ; KIURA, Katsuyuki ; UEOKA, Hiroshi ; TANIMOTO, Mitsune ; KISHINO, Daizo ; FUJIWARA, Keiichi ; TOKUDA, Yoshiyuki ; SEKI, Nobuhiko ; SHINKAI, Tetsu ; WATANABE, Yoichi ; HIRAKI, Shunkichi ; KOZUKI, Toshiyuki

Cancer chemotherapy and pharmacology, 2004-09, Vol.54 (3), p.230-236 [Periódico revisado por pares]

Berlin: Springer

Texto completo disponível

Citações Citado por
6
Phase I/II study of altered schedule of cisplatin and etoposide administration and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small-cell lung cancer
Phase I/II study of altered schedule of cisplatin and etoposide administration and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I/II study of altered schedule of cisplatin and etoposide administration and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small-cell lung cancer

Segawa, Yoshihiko ; Ueoka, Hiroshi ; Kiura, Katsuyuki ; Tabata, Masahiro ; Takigawa, Nagio ; Hiraki, Yoshio ; Watanabe, Yoichi ; Yonei, Toshiro ; Moritaka, Tomonori ; Hiyama, Junichiro ; Hiraki, Shunkichi ; Tanimoto, Mitsune ; Harada, Mine

Lung cancer (Amsterdam, Netherlands), 2003-07, Vol.41 (1), p.13-20 [Periódico revisado por pares]

Shannon: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
7
Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group
Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group

UEOKA, H ; TANIMOTO, M ; KAMEI, H ; SHIBAYAMA, T ; WATANABE, Y ; HIRAKI, S ; HARADA, M ; KIURA, K ; TABATA, M ; TAKIGAWA, N ; SEGAWA, Y ; TAKATA, I ; EGUCHI, K ; OKIMOTO, N ; HARITA, S

British journal of cancer, 2001-07, Vol.85 (1), p.9-13 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors
A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors

Kodani, Tsuyoshi ; Ueoka, Hiroshi ; Kiura, Katsuyuki ; Tabata, Masahiro ; Takigawa, Nagio ; Segawa, Yoshihiko ; Moritaka, Tomonori ; Hiraki, Shunkichi ; Harada, Mine ; Tanimoto, Mitsune

Lung cancer (Amsterdam, Netherlands), 2002-06, Vol.36 (3), p.313-319 [Periódico revisado por pares]

Shannon: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
9
A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group
A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group

SEGAWA, Y ; UEOKA, H ; HARADA, M ; KIURA, K ; KAMEI, H ; TABATA, M ; SAKAE, K ; HIRAKI, Y ; KAWAHARA, S ; EGUCHI, K ; HIRAKI, S

British journal of cancer, 2000-01, Vol.82 (1), p.104-111 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study
Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study

UEOKA, H ; TABATA, M ; KIURA, K ; SHIBAYAMA, T ; GEMBA, K ; SEGAWA, Y ; CHIKAMORI, K ; YONEI, T ; HIRAKI, S ; HARADA, M

British journal of cancer, 1999-02, Vol.79 (5-6), p.984-990 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (14)

Data de Publicação 

De até
Refinar
  1. Antes de1998  (3)
  2. 1998Até1999  (2)
  3. 2000Até2001  (4)
  4. 2002Até2004  (6)
  5. Após 2004  (1)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.